FIELD: medicine. SUBSTANCE: content of lipid-bound sialic acid (LSA), DNA and specific activity of DNA-binding proteins are measured in blood of patients with myelodisplastic syndrome in connection with minimal bone marrow blastosis (less than 10% blast cells). Acute leukosis is diagnosed in the case of simultaneous change all three indices (LSA content is increased up to 0,2 g/l and above, DNA - up to 7,5 micro g/l and DNA-binding proteins is decreased up to 14 U/mg protein and above). Method ensures to provide early detection of acute leukosis in patients with myelodisplastic syndrome. EFFECT: improved method of diagnosis. 1 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PREDICTING MYELODYSPLASTIC SYNDROME DEVELOPMENT COURSE | 2000 |
|
RU2213975C2 |
METHOD FOR DETERMINING IMMUNODEPRESSANT THERAPY TACTICS IN THE CASES OF MYELODYSPLASTIC SYNDROME | 2000 |
|
RU2212037C2 |
METHOD FOR OBTAINING PREPARATIONS OF METAPHASE CHROMOSOMES OUT OF BONE MARROW CELLS IN HEMOBLASTOSESSUFFERING PATIENTS | 2000 |
|
RU2200318C2 |
METHOD FOR DETERMINING ACUTE LEUKOSIS IN INFANTS | 1987 |
|
SU1543997A1 |
METHOD OF DETERMINING FACTORS OF PREDICTION OF SEVERE HEMORRHAGIC COMPLICATIONS IN PATIENTS WITH ACUTE PROMYELOCYTIC LEUKEMIA IN DIAGNOSTICS | 2009 |
|
RU2400750C1 |
METHOD OF PREPARING ORGANOSPECIFIC HOMEOPATHIC PREPARATIONS STIMULATING MYELOID AND LYMPHOID HEMOPOIESIS STEMS | 1995 |
|
RU2083213C1 |
METHOD OF PREDICTING RECURRENCIES OF ACUTE LYMPHOBLASTIC LEUKOSIS | 0 |
|
SU1589215A1 |
METHOD FOR LABORATORY VERIFICATION OF INFECTIONS IN PATIENTS WITH ACUTE MANIFESTED MYELOID LEUKEMIA | 2011 |
|
RU2462711C1 |
METHOD OF INDUCING REMISSION IN PATIENTS SUFFERING ACQUIRED APLASTIC ANAEMIA | 2008 |
|
RU2412708C2 |
DIAGNOSTIC TECHNIQUE FOR INFECTION IN PATIENTS WITH MANIFESTED ACUTE LYMPHOBLASTIC LEUKAEMIA | 2013 |
|
RU2535057C1 |
Authors
Dates
1994-02-15—Published
1991-06-19—Filed